These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21873152)
1. KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer. Fujimoto T; Shirasawa S Anticancer Res; 2011 Jul; 31(7):2413-7. PubMed ID: 21873152 [TBL] [Abstract][Full Text] [Related]
2. Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. Fujimoto T; Miyasaka K; Koyanagi M; Tsunoda T; Baba I; Doi K; Ohta M; Kato N; Sasazuki T; Shirasawa S PLoS One; 2009; 4(1):e4240. PubMed ID: 19156225 [TBL] [Abstract][Full Text] [Related]
3. Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line. Fujimoto T; Koyanagi M; Baba I; Nakabayashi K; Kato N; Sasazuki T; Shirasawa S J Hum Genet; 2007; 52(12):978-984. PubMed ID: 17934691 [TBL] [Abstract][Full Text] [Related]
4. Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor. Fujimoto T; Machida T; Tsunoda T; Doi K; Ota T; Kuroki M; Shirasawa S Biochem Biophys Res Commun; 2011 May; 408(2):282-6. PubMed ID: 21501587 [TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. Inokuchi J; Komiya M; Baba I; Naito S; Sasazuki T; Shirasawa S J Hum Genet; 2004; 49(1):46-52. PubMed ID: 14673706 [TBL] [Abstract][Full Text] [Related]
6. Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP3R in the stomach and kidney. Fujimoto T; Shirasawa S Int J Mol Med; 2012 Dec; 30(6):1287-93. PubMed ID: 22992961 [TBL] [Abstract][Full Text] [Related]
7. KRAS-induced actin-interacting protein regulates inositol 1,4,5-trisphosphate-receptor-mediated calcium release. Fujimoto T; Machida T; Tsunoda T; Doi K; Ota T; Kuroki M; Shirasawa S Biochem Biophys Res Commun; 2011 May; 408(2):214-7. PubMed ID: 21457704 [TBL] [Abstract][Full Text] [Related]
8. KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells. Fujimoto T; Machida T; Tanaka Y; Tsunoda T; Doi K; Ota T; Okamura T; Kuroki M; Shirasawa S Biochem Biophys Res Commun; 2011 Apr; 407(2):438-43. PubMed ID: 21420385 [TBL] [Abstract][Full Text] [Related]
9. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy. Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899 [TBL] [Abstract][Full Text] [Related]
11. Vimentin and the K-Ras-induced actin-binding protein control inositol-(1,4,5)-trisphosphate receptor redistribution during MDCK cell differentiation. Dingli F; Parys JB; Loew D; Saule S; Mery L J Cell Sci; 2012 Nov; 125(Pt 22):5428-40. PubMed ID: 22946050 [TBL] [Abstract][Full Text] [Related]
12. Kras in metastatic colorectal cancer. Wicki A; Herrmann R; Christofori G Swiss Med Wkly; 2010; 140():w13112. PubMed ID: 21104470 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159 [TBL] [Abstract][Full Text] [Related]
14. Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors. Seruca R; Velho S; Oliveira C; Leite M; Matos P; Jordan P Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):5-9. PubMed ID: 19210107 [No Abstract] [Full Text] [Related]
15. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002 [TBL] [Abstract][Full Text] [Related]
16. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants. Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL Cells; 2019 Dec; 8(12):. PubMed ID: 31816869 [TBL] [Abstract][Full Text] [Related]
17. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267 [TBL] [Abstract][Full Text] [Related]